abs81.txt	breast	cancer	remains	a	leading	cause	of	death	for	women	throughout	the	world	recent	advances	in	medical	imaging	technologies	and	tumor	targeting	agentssignify	vast	potential	progress	toward	improved	management	this	globalproblem		phase-change	contrast	agents	(pccas)	are	dynamic	withpractical	applications	both	research	clinical	settings	pccas	possesscharacteristics	that	allow	cellular	uptake	where	they	can	be	converted	fromliquid-phase	to	gaseous	microbubbles	via	ultrasound	energy	previously	wereported	successful	internalization	folate-targeted	mda-mb-231	breastcancer	cells	followed	by	ultrasound-mediated	activation	produce	internalizedmicrobubbles	study	examines	binding	offolate-receptor	targeted	as	function	ofgaseous	core	compositions	incubation	time	exposure	period	invitro	results	indicate	ofpccas	were	significantly	greater	using	50	mixture	ofdecafluorobutane	dodecafluoropentane	compared	with	other	50octafluoropropane	decafluorobutane	(p	<	0	0001)	04)	anddodecafluoropentane	furthermore	it	was	found	composedof	perfluorocarbons	higher	boiling	points	responded	activationefficiency	when	exposed	12s	opposed	4s	ofultrasound	evaluating	different	times	foundthat	incubating	60min	did	not	producesignificantly	for10	min	concluded	after	comparing	number	present	percell	before	versus	post-ultrasound	finding	ratio	ofintracellular	post-ultrasound/pre-ultrasound	3	46	14	respectively	data	collected	helps	illustrate	furtheroptimization	folate-receptor	andimaging
